Sort
39,280 grants matching “leukemia”
Anticancer Agent Pharmacodynamics in Acute Leukemia
$468,296St. Jude Children'S Research Hospital · R01 · FY2003 · CA
Targeting the Notch:Myc axis in leukemia/lymphoma
$468,293Warren S Pear · University Of Pennsylvania · R01 · FY2018 · CA
Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio
$468,268Claudio Anasetti · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · HL
LY-1 B CELLS: DEVELOPMENTAL ORIGINS AND V GENE BIASES
$468,256Institute For Cancer Research · R01 · FY2005 · AI
Targeting the MLL-WDR5 protein-protein interaction
$468,214Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2013 · CA
Targeting the MLL-WDR5 protein-protein interaction
$468,214Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding
$468,199Lucas Ferrari De Andrade · Icahn School Of Medicine At Mount Sinai · R37 · FY2024 · CA
SOUTHWEST ONCOLOGY GROUP
$468,138Swedish Medical Center, First Hill · U10 · FY2003 · CA
Dissecting stress granule dependencies in leukemia stem cells
$467,966Eugene Wei-Ming Yeo · University Of California, San Diego · R01 · FY2023 · CA
Cellular Transduction with Replication-Competent Retrovirus Vectors
$467,899Noriyuki Kasahara · University Of California Los Angeles · R01 · FY2008 · CA
Dietary and Lifestyle Determinants of Colon Cancer Recurrence and Survival
$467,879Charles S Fuchs · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Tyrosine Kinases and Thrombosis
$467,830Alvin H Schmaier · Case Western Reserve University · R01 · FY2023 · HL
GENETIC ANALYSIS OF ZEBRAFISH EMBRYO DEVELOPMENT
$467,824Paul Liu · National Human Genome Research Institute · ZIA · FY2011 · HG
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
$467,801Derek L Stirewalt · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Human Platelet Defects in Transcription Factor RUNX1 Haplodeficiency
$467,731A Koneti Rao · Temple Univ Of The Commonwealth · R01 · FY2020 · HL
DRUG METABOLISM IN CHILDHOOD CANCER
$467,714St. Jude Children'S Research Hospital · R37 · FY2002 · CA
TLI/ATG CONDTIONING: KIDNEY/BLOOD STEM CELL TRANSPLANTS
$467,693Samuel Strober · Stanford University · P01 · FY2006 · HL
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and Survival
$467,689Charles S Fuchs · Yale University · R01 · FY2017 · CA
Dearomatization Reactions in Synthesis
$467,629Christopher M Beaudry · Oregon State University · · FY2020 · MPS
Diagnosis of Cancer in the Emergency Room - Explaining Persistent Disparities
$467,569Caroline Avery Thompson · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Mechanisms of STING in malignant progression and therapy of CLL.
$467,536Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2024 · CA
Prevention of Platelet Alloimmunization by Costimulatory Blockade
$467,500James C. Zimring · Bloodworks · R01 · FY2016 · HL
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
$467,500Neil Johnson · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · HL
Prevention of Platelet Alloimmunization by Costimulatory Blockade
$467,500James C. Zimring · Bloodworks · R01 · FY2014 · HL
The role of microhomology-mediated end joining in Fanconi anemia pathogenesis
$467,500Neil Johnson · Research Inst Of Fox Chase Can Ctr · R01 · FY2020 · HL